Cited 0 times in
Cited 4 times in
Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박승우 | - |
dc.contributor.author | 박정엽 | - |
dc.contributor.author | 방승민 | - |
dc.contributor.author | 송시영 | - |
dc.contributor.author | 이희승 | - |
dc.contributor.author | 정다운 | - |
dc.contributor.author | 정문재 | - |
dc.contributor.author | 조중현 | - |
dc.date.accessioned | 2024-05-23T03:03:36Z | - |
dc.date.available | 2024-05-23T03:03:36Z | - |
dc.date.issued | 2024-03 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/199145 | - |
dc.description.abstract | Biliary tract cancer (BTC) is a relatively rare but aggressive gastrointestinal cancer with a high mortality rate. Cancer stem cell (CSC) populations play crucial roles in tumor biology and are responsible for the low response to anti-cancer treatment and the high recurrence rate. This study investigated the role of Transgelin-2 (TAGLN2), overexpressed in CSC in BTC cells, and analyzed its expression in patient tissues and serum to identify potential new targets for BTC. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | BioMed Central | - |
dc.relation.isPartOf | BMC CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Biliary Tract Neoplasms* / drug therapy | - |
dc.subject.MESH | Biliary Tract Neoplasms* / genetics | - |
dc.subject.MESH | Biomarkers, Tumor / genetics | - |
dc.subject.MESH | Biomarkers, Tumor / metabolism | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Microfilament Proteins* / genetics | - |
dc.subject.MESH | Microfilament Proteins* / metabolism | - |
dc.subject.MESH | Muscle Proteins / genetics | - |
dc.title | Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jung Hyun Jo | - |
dc.contributor.googleauthor | Soo Been Park | - |
dc.contributor.googleauthor | Joowon Chung | - |
dc.contributor.googleauthor | Taeyun Oh | - |
dc.contributor.googleauthor | Hee Seung Lee | - |
dc.contributor.googleauthor | Moon Jae Chung | - |
dc.contributor.googleauthor | Jeong Youp Park | - |
dc.contributor.googleauthor | Seungmin Bang | - |
dc.contributor.googleauthor | Seung Woo Park | - |
dc.contributor.googleauthor | Dawoon E Jung | - |
dc.contributor.googleauthor | Si Young Song | - |
dc.identifier.doi | 10.1186/s12885-024-12082-3 | - |
dc.contributor.localId | A01551 | - |
dc.contributor.localId | A01647 | - |
dc.contributor.localId | A01786 | - |
dc.contributor.localId | A02035 | - |
dc.contributor.localId | A03349 | - |
dc.contributor.localId | A03587 | - |
dc.contributor.localId | A03602 | - |
dc.contributor.localId | A03912 | - |
dc.relation.journalcode | J00351 | - |
dc.identifier.eissn | 1471-2407 | - |
dc.identifier.pmid | 38509504 | - |
dc.subject.keyword | Biliary tract cancer | - |
dc.subject.keyword | Cancer stem cell | - |
dc.subject.keyword | Cancer-associated fibroblasts | - |
dc.subject.keyword | Therapy-resistance | - |
dc.subject.keyword | Transgelin-2 | - |
dc.contributor.alternativeName | Park, Seung Woo | - |
dc.contributor.affiliatedAuthor | 박승우 | - |
dc.contributor.affiliatedAuthor | 박정엽 | - |
dc.contributor.affiliatedAuthor | 방승민 | - |
dc.contributor.affiliatedAuthor | 송시영 | - |
dc.contributor.affiliatedAuthor | 이희승 | - |
dc.contributor.affiliatedAuthor | 정다운 | - |
dc.contributor.affiliatedAuthor | 정문재 | - |
dc.contributor.affiliatedAuthor | 조중현 | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 357 | - |
dc.identifier.bibliographicCitation | BMC CANCER, Vol.24(1) : 357, 2024-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.